Chemotherapy-Induced Neuropathy in Cancer Survivors.

ABSTRACT:

Context

Evidence suggests that chemotherapy-induced neuropathy (CIN) is a significant problem for cancer survivors. However, a detailed phenotypic characterization of CIN in cancer survivors is not available.

Objectives

To evaluate between-group differences in demographic and clinical characteristics, as well as in measures of sensation, function, and postural control, in a sample of cancer survivors who received a platinum and/or a taxane-based CTX regimen and did (n = 426) and did not (n = 197) develop CIN.

Methods

Survivors completed self-report questionnaires and underwent objective testing (i.e., light touch, pain sensation, cold sensation, vibration, muscle strength, grip strength, Purdue Pegboard test, Timed Get Up and Go test, Fullerton Advanced Balance test).

SUBMITTER: Miaskowski C 

PROVIDER: S-EPMC5496793 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature